Stock Detail
ISHARES DIVERSIFIED ALTERNATIVES TRUST ETF
Drugs
ALT @ Yahoo Finance | ALT Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $48.70 | $49.25 | $0.00 | 0.00% | 0.00 | $49.00 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $49.25 | $48.70 | 219,265 | 0 | 30,894 | 1.00 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 49.43 | 49.06 | 48.88 | 48.51 | 48.33 |
Stock Profile
Alteon, Inc. engages in the discovery and development of small molecule drugs for diseases of aging and complications of diabetes. Its pharmaceutical candidates are based on Advanced Glycation End-Products pathway, a fundamental pathological process and inevitable consequence of aging that causes or contributes to medical disorders, such as cardiovascular, kidney, and eye diseases. The company's lead compound, alagebrium chloride, is in Phase 2 clinical development for systolic hypertension, diastolic dysfunction in heart failure, and erectile dysfunction. The company was incorporated in 1986 as Geritech, Inc. and its name was changed to Alteon, Inc. in 1991. Alteon is headquartered in Parsippany, New Jersey.